Skip To Main Content

This website is intended exclusively for the healthcare professionals residing and/or working in Thailand.

Welcome To Campus Sanofi Thailand

Do you already have an account on Campus Sanofi?

What’s New

Explore the latest scientific articles, videos, medical insights and trends

Find your answer to help adults with insufficiently controlled T2D get to target HbA1c<sup>2-6</sup>

Find your answer to help adults with insufficiently controlled T2D get to target HbA1c^2-6

Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA

Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA

Cancer-Associated VTE: Balancing Recurrence, Bleeding, and Clinical Risk

Cancer-Associated VTE: Balancing Recurrence, Bleeding, and Clinical Risk

FRC vs Premix insulin: Key Study Findings

FRC vs Premix insulin: Key Study Findings

Thai Clinical Practice Guideline for the use of Nirsevimab

Thai Clinical Practice Guideline for the use of Nirsevimab

Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+

Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+

ATS 2025 Scientific Highlights

ATS 2025 Scientific Highlights

May 17–21, 2025; San Francisco, California, US

Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study

Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study